|
市場調査レポート
商品コード
1463622
中南米のバイオ医薬品向け凍結乾燥サービス：2028年までの市場予測 - 地域分析 - サービスタイプ別、エンドユーザー別South & Central America Lyophilization Services for Biopharmaceuticals Market Forecast to 2028 - Regional Analysis - by Service Type and End-User |
||||||
|
|
|||||||
|
|||||||
| 中南米のバイオ医薬品向け凍結乾燥サービス：2028年までの市場予測 - 地域分析 - サービスタイプ別、エンドユーザー別 |
|
出版日: 2024年01月23日
発行: The Insight Partners
ページ情報: 英文 95 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
中南米のバイオ医薬品向け凍結乾燥サービス市場は、2023年に7,002万米ドルと評価され、2028年には1億437万米ドルに達すると予測され、2023年から2028年までのCAGRは8.3%で成長すると予測されています。
受託製造と凍結乾燥サービスの急成長が中南米のバイオ医薬品向け凍結乾燥サービス市場を牽引
バイオ医薬品市場は世界中で拡大を続けており、製薬業界の主要な成長要因となっています。バイオ医薬品の非経口剤製造は、より多くの治療用生物製剤が承認されたため、最近拡大しています。バイオテクノロジー企業は、充填・仕上げのニーズを満たし、微生物汚染のリスクを低減するために、受託製造機関（CMO）に委託しています。バイオ医薬品企業は、必要に応じて能力と能力を提供する製造受託機関（CMO）に依存しており、場合によっては、CMOが企業の製造の大部分を担っています。
社内で凍結乾燥能力とオペレーションを立ち上げるには、特殊な設備と専門知識が必要であり、費用と時間がかかります。しかし、アウトソーシングは安価であり、製造工程の効率を高める。さらに、バイオテクノロジー企業はリソースを他の分野に振り向けることができます。このように、医薬品開発企業やバイオ医薬品企業は、生産コストや歩留まりコストを全体的に節約するために、このような業務をCMOに委託しています。数年前まで、CMO業界はニッチなサービス市場であり、バイオテクノロジー企業に追加の製造能力や特定のサービスを提供していました。現在では、多くのバイオテクノロジー企業が、初期段階の医薬品開発から商業規模の製造まで、様々なサービスを外注しています。バイオテクノロジー産業が大規模生産からニッチ治療や標的治療（個別化医療）へとシフトするにつれ、柔軟な操業能力、生産規模、多品種生産への需要が高まっています。こうしたすべての要因から、CMOへの傾倒が高まっています。このように、バイオ医薬品CMOの能力と利用可能性の高まりが、中南米のバイオ医薬品向け凍結乾燥サービス市場の成長を後押ししています。
中南米のバイオ医薬品凍結乾燥市場概要
中南米地域は、ブラジル、アルゼンチン、その他中南米で構成されます。この地域ではブラジルが大きな市場シェアを占めると予想されます。同市場は、製薬・バイオ医薬品産業における研究開発のための巨額の投資により、良好な成長機会を有すると考えられます。加えて、外国の当局や組織との協力関係により、これらの国々では凍結乾燥サービスの需要が高まっています。
中南米のバイオ医薬品向け凍結乾燥サービス市場の収益と2028年までの予測（US$Mn）
中南米のバイオ医薬品向け凍結乾燥サービス市場セグメンテーション
中南米のバイオ医薬品向け凍結乾燥サービス市場は、サービスタイプ、エンドユーザー、国別にセグメント化されています。
サービスタイプに基づき、中南米のバイオ医薬品向け凍結乾燥サービス市場は、凍結乾燥サイクル開発、臨床製造、商業製造、凍結乾燥分析サービスに区分されます。商業製造セグメントが2023年に最大の市場シェアを占めました。
エンドユーザーに基づき、中南米のバイオ医薬品向け凍結乾燥サービス市場は製薬＆バイオテクノロジー企業、研究機関、その他に区分されます。製薬＆バイオテクノロジー企業セグメントが2023年に最大の市場シェアを占めました。
国別に見ると、中南米のバイオ医薬品向け凍結乾燥サービス市場は、ブラジル、アルゼンチン、その他南米に区分されます。2023年の中南米のバイオ医薬品向け凍結乾燥サービス市場シェアは、ブラジルが圧倒的でした。
ABB社、Azbil Corporation社、Curia Global Inc社、Grifols S.A.社、Jubilant HollisterStier LLC社、OPTIMA社は、中南米のバイオ医薬品用凍結乾燥サービス市場で事業を展開している大手企業の一部です。
目次
第1章 イントロダクション
第2章 バイオ医薬品向け凍結乾燥サービスの中南米市場：要点
第3章 調査手法
- 調査範囲
- 2次調査
- 1次調査
第4章 バイオ医薬品向け凍結乾燥サービスの南米市場情勢
- 中南米のPEST分析
- 専門家の見解
第5章 中南米のバイオ医薬品向け凍結乾燥サービス市場：主要市場力学
- 市場促進要因
- 凍結乾燥製品に対する需要の高まり
- 受託製造及び凍結乾燥サービスの急成長
- 市場抑制要因
- 凍結乾燥プロセスに伴うデメリット
- 市場機会
- 高度な凍結乾燥技術の登場
- 今後の動向
- siRNAおよび抗体ベースの製剤数の増加
- 促進要因と阻害要因の影響分析
第6章 バイオ医薬品向け凍結乾燥サービス市場：中南米分析
- 中南米のバイオ医薬品向け凍結乾燥サービス市場収益と予測分析
第7章 中南米のバイオ医薬品向け凍結乾燥サービス市場 - 分析と2028年までの予測：サービスタイプ別
- 中南米のバイオ医薬品向け凍結乾燥サービス市場：サービスタイプ別2022年・2028年（%）
- 商業用製造
- 臨床製造
- 凍結乾燥サイクル開発
- 凍結乾燥分析サービス
第8章 中南米のバイオ医薬品向け凍結乾燥サービス市場 - 分析と2028年までの予測：エンドユーザー別
- 中南米のバイオ医薬品向け凍結乾燥サービス市場：エンドユーザー別2022年・2028年（%）
- 製薬企業およびバイオテクノロジー企業
- 研究機関
- その他
第9章 中南米のバイオ医薬品向け凍結乾燥サービス市場 - 収益と2028年までの予測：国別分析
- ブラジル
- アルゼンチン
- その他中南米
第10章 中南米のバイオ医薬品向け凍結乾燥サービス市場：業界情勢
- 中南米のバイオ医薬品向け凍結乾燥サービス市場の成長戦略
- 無機的成長戦略
- 有機的成長戦略
第11章 企業プロファイル
- ABB
- Azbil Corporation
- Curia Global Inc
- Jubilant HollisterStier LLC.
- Optima Pharma GmbH
- Grifols SA
第12章 付録
List Of Tables
- Table 1. Brazil: South & Central America Lyophilization Services for Biopharmaceuticals Market, by Service Type- Revenue and Forecast to 2028 (US$ Million)
- Table 2. Brazil: South & Central America Lyophilization Services for Biopharmaceuticals Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 3. Argentina: South & Central America Lyophilization Services for Biopharmaceuticals Market, by Service Type- Revenue and Forecast to 2028 (US$ Million)
- Table 4. Argentina: South & Central America Lyophilization Services for Biopharmaceuticals Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 5. Rest of South & Central America: South & Central America Lyophilization Services for Biopharmaceuticals Market, by Service Type- Revenue and Forecast to 2028 (US$ Million)
- Table 6. Rest of South & Central America: South & Central America Lyophilization Services for Biopharmaceuticals Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 7. Recent Inorganic Growth Strategies in the South & Central America Lyophilization Services for Biopharmaceuticals Market
- Table 8. Recent Organic Growth Strategies in the South & Central America Lyophilization Services for Biopharmaceuticals Market
- Table 9. Glossary of Terms
List Of Figures
- Figure 1. South & Central America Lyophilization Services for Biopharmaceuticals Market Segmentation
- Figure 2. South & Central America Lyophilization Services for Biopharmaceuticals Market, by Country
- Figure 3. South & Central America Lyophilization Services for Biopharmaceuticals Market Overview
- Figure 4. Commercial Manufacturing Segment Held Largest Share of Service Type Segment in South & Central America Lyophilization Services for Biopharmaceuticals Market
- Figure 5. Brazil Expected to Show Remarkable Growth During Forecast Period
- Figure 6. South & Central America: PEST Analysis
- Figure 7. Experts' Opinion
- Figure 8. South & Central America Lyophilization Services for Biopharmaceuticals Market Impact Analysis of Drivers and Restraint
- Figure 9. South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue Forecast and Analysis - 2020-2028
- Figure 10. South & Central America Lyophilization Services for Biopharmaceuticals Market, by Service Type 2022 & 2028 (%)
- Figure 11. Commercial Manufacturing: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 12. Clinical Manufacturing: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 13. Lyophilization Cycle Development: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 14. Freeze Drying Analytical Services: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 15. South & Central America Lyophilization Services for Biopharmaceuticals Market, by End User, 2022 & 2028 (%)
- Figure 16. Pharmaceutical and Biotechnology Companies: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 17. Research Institutes: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 18. Others: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 19. South & Central America Lyophilization Services for Biopharmaceuticals Market, by Key Country - Revenue (2022) (US$ Million)
- Figure 20. South & Central America Lyophilization Services for Biopharmaceuticals Market, by Country, 2022 & 2028 (%)
- Figure 21. Brazil: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 22. Argentina: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 23. Rest of South & Central America: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 24. Growth Strategies in the South & Central America Lyophilization Services for Biopharmaceuticals Market
The South & Central America lyophilization services for biopharmaceuticals market was valued at US$ 70.02 million in 2023 and is expected to reach US$ 104.37 million by 2028; it is estimated to grow at a CAGR of 8.3% from 2023 to 2028.
Rapid Growth in Contract Manufacturing and Lyophilization Services Fuels the South & Central America Lyophilization Services for Biopharmaceuticals Market
The biopharmaceuticals market continues to expand across the world, which can be the primary growth driver for the pharmaceutical industry. Biopharmaceutical parenteral manufacturing has expanded recently as more therapeutic biologics have been approved. Biotechnology companies outsource from contract manufacturing organizations (CMOs) to meet their fill-and-finish needs and reduce the risk of microbial contamination. Biopharma companies are dependent on contract manufacturing organizations (CMOs) to provide capacity and capabilities as needed; in some cases, CMOs provide a great deal of a company's production.
Setting up in-house lyophilization capabilities and operations requires specialized equipment and expertise, which is an expensive and time-consuming. However, outsourcing is cheaper and increases the efficiency of manufacturing processes. Additionally, it allows biotechnology companies to redirect resources to other areas. Thus, drug developers and biopharmaceutical companies outsource such operations to CMOs to save overall production and yield cost. A few years ago, the CMO industry was a niche service market, offering additional manufacturing capacity or specific services to biotechnology companies. Now, many biotechnology companies outsource various services, from early-stage drug development to commercial-scale manufacturing. As the biotechnology industry is shifting from large-scale production to niche and targeted therapies (personalized medicine), the demand for flexible operational capabilities, production scales, and multiple-product operations is rising. Owing to all these factors, the inclination toward CMOs is growing. Thus, the rising capability and availability of biopharma CMOs fuel the South & Central America lyophilization service for biopharmaceuticals market growth.
South & Central America Lyophilization Services for Biopharmaceuticals Market Overview
South and Central America region consist of Brazil, Argentina, and the Rest of the South and Central America. Brazil is expected to have a major market share in this region. The market is likely to have good growth opportunities owing to the huge investment for research and development in the pharmaceutical and biopharmaceutical industry. In addition, the collaboration with foreign authorities and organizations is likely to demand the lyophilization services in the countries.
South & Central America Lyophilization Services for Biopharmaceuticals Market Revenue and Forecast to 2028 (US$ Mn)
South & Central America Lyophilization Services for Biopharmaceuticals Market Segmentation
The South & Central America lyophilization services for biopharmaceuticals market is segmented service type, end user, and country.
Based on service type, the South & Central America lyophilization services for biopharmaceuticals market is segmented into lyophilization cycle development, clinical manufacturing, commercial manufacturing, and freeze drying analytical services. The commercial manufacturing segment held the largest market share in 2023.
Based on end-user, the South & Central America lyophilization services for biopharmaceuticals market is segmented into pharmaceutical & biotechnology companies, research institutes, and other. The pharmaceutical & biotechnology companies segment held the largest market share in 2023.
Based on country, the South & Central America lyophilization services for biopharmaceuticals market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America lyophilization services for biopharmaceuticals market share in 2023.
ABB, Azbil Corporation, Curia Global Inc, Grifols S.A., Jubilant HollisterStier LLC., and OPTIMA are some of the leading companies operating in the South & Central America lyophilization services for biopharmaceuticals market.
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 South & Central America Lyophilization Services for Biopharmaceuticals Market - by Service Type
- 1.3.2 South & Central America Lyophilization Services for Biopharmaceuticals Market - by End User
- 1.3.3 South & Central America Lyophilization Services for Biopharmaceuticals Market - by Country
2. South & Central America Lyophilization Services for Biopharmaceuticals Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. South & Central America Lyophilization Services for Biopharmaceuticals Market - Market Landscape
- 4.1 Overview
- 4.2 South & Central America PEST Analysis
- 4.3 Expert's Opinion
5. South & Central America Lyophilization Services for Biopharmaceuticals Market - Key Market Dynamics
- 5.1 Market Driver
- 5.1.1 Rising Demand for Lyophilized Products
- 5.1.2 Rapid Growth in Contract Manufacturing and Lyophilization Services
- 5.2 Market Restraints
- 5.2.1 Demerits Associated with Lyophilization Process
- 5.3 Market Opportunities
- 5.3.1 Launch of Advanced Lyophilization Technology
- 5.4 Future Trends
- 5.4.1 Growing Number of siRNA and Antibody-Based Formulations
- 5.5 Impact Analysis of Drivers and Restraints
6. Lyophilization Services for Biopharmaceuticals Market - South & Central America Analysis
- 6.1 South & Central America Lyophilization Services for Biopharmaceuticals Market Revenue Forecast and Analysis
7. South & Central America Lyophilization Services for Biopharmaceuticals Market Analysis and Forecast to 2028 - by Service Type
- 7.1 Overview
- 7.2 South & Central America Lyophilization Services for Biopharmaceuticals Market, by Service Type 2022 & 2028 (%)
- 7.3 Commercial Manufacturing
- 7.3.1 Overview
- 7.3.2 Commercial Manufacturing: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4 Clinical Manufacturing
- 7.4.1 Overview
- 7.4.2 Clinical Manufacturing: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5 Lyophilization Cycle Development
- 7.5.1 Overview
- 7.5.2 Lyophilization Cycle Development: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6 Freeze Drying Analytical Services
- 7.6.1 Overview
- 7.6.2 Freeze Drying Analytical Services: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8. South & Central America Lyophilization Services for Biopharmaceuticals Market Analysis and Forecast to 2028 - by End User
- 8.1 Overview
- 8.2 South & Central America Lyophilization Services for Biopharmaceuticals Market, by End User, 2022 & 2028 (%)
- 8.3 Pharmaceutical and Biotechnology Companies
- 8.3.1 Overview
- 8.3.2 Pharmaceutical and Biotechnology Companies: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Research Institutes
- 8.4.1 Overview
- 8.4.2 Research Institutes: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
9. South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 - Country Analysis
- 9.1 Overview
- 9.1.1 South & Central America Lyophilization Services for Biopharmaceuticals Market, by Country, 2022 & 2028 (%)
- 9.1.1.1 Brazil: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.1.1 Overview
- 9.1.1.1.2 Brazil: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.1.3 Brazil: South & Central America Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
- 9.1.1.1.4 Brazil: South & Central America Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
- 9.1.1.2 Argentina: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.2.1 Overview
- 9.1.1.2.2 Argentina: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.2.3 Argentina: South & Central America Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
- 9.1.1.2.4 Argentina: South & Central America Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
- 9.1.1.3 Rest of South & Central America: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.3.1 Overview
- 9.1.1.3.2 Rest of South & Central America: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.3.3 Rest of South & Central America: South & Central America Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
- 9.1.1.3.4 Rest of South & Central America: South & Central America Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
- 9.1.1.1 Brazil: South & Central America Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1 South & Central America Lyophilization Services for Biopharmaceuticals Market, by Country, 2022 & 2028 (%)
10. South & Central America Lyophilization Services for Biopharmaceuticals Market - Industry Landscape
- 10.1 Overview
- 10.2 Growth Strategies in the South & Central America Lyophilization Services for Biopharmaceuticals Market
- 10.3 Inorganic Growth Strategies
- 10.3.1 Overview
- 10.4 Organic Growth Strategies
- 10.4.1 Overview
11. Company Profiles
- 11.1 ABB
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
- 11.2 Azbil Corporation
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
- 11.3 Curia Global Inc
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
- 11.4 Jubilant HollisterStier LLC.
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
- 11.5 Optima Pharma GmbH
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
- 11.6 Grifols SA
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
12. Appendix
- 12.1 About The Insight Partners
- 12.2 Glossary of Terms
